Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment

被引：0
|
作者：
Ruiwen Ruan
Li Li
Xuan Li
Chunye Huang
Zhanmin Zhang
Hongguang Zhong
Shaocheng Zeng
Qianqian Shi
Yang Xia
Qinru Zeng
Qin Wen
Jingyi Chen
Xiaofeng Dai
Jianping Xiong
Xiaojun Xiang
Wan Lei
Jun Deng
机构：
[1] First Affiliated Hospital of Nanchang University,Department of Oncology
[2] Jiangxi Key Laboratory for lndividualized Cancer Therapy,undefined
来源：
Molecular Cancer | / 22卷
关键词：
Fibroblast growth factor receptor; Immune checkpoint blockade; Tumor microenvironment; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
    Ruan, Ruiwen
    Li, Li
    Li, Xuan
    Huang, Chunye
    Zhang, Zhanmin
    Zhong, Hongguang
    Zeng, Shaocheng
    Shi, Qianqian
    Xia, Yang
    Zeng, Qinru
    Wen, Qin
    Chen, Jingyi
    Dai, Xiaofeng
    Xiong, Jianping
    Xiang, Xiaojun
    Lei, Wan
    Deng, Jun
    MOLECULAR CANCER, 2023, 22 (01)
  • [2] Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade
    Akhand, Saeed S.
    Liu, Zian
    Purdy, Stephen C.
    Abdullah, Ammara
    Lin, Hang
    Cresswell, Gregory M.
    Ratliff, Timothy L.
    Wendt, Michael
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (12) : 1542 - 1553
  • [3] FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report
    Roussot, Nicolas
    Lecuelle, Julie
    Dalens, Lorraine
    Truntzer, Caroline
    Ghiringhelli, Francois
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
  • [4] The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
    Komura, Kazumasa
    Hirosuna, Kensuke
    Tokushige, Satoshi
    Tsujino, Takuya
    Nishimura, Kazuki
    Ishida, Mitsuaki
    Hayashi, Takuo
    Ura, Ayako
    Ohno, Takaya
    Yamazaki, Shogo
    Nakamori, Keita
    Kinoshita, Shoko
    Maenosono, Ryoichi
    Ajiro, Masahiko
    Yoshikawa, Yuki
    Takai, Tomoaki
    Tsutsumi, Takeshi
    Taniguchi, Kohei
    Tanaka, Tomohito
    Takahara, Kiyoshi
    Konuma, Tsuyoshi
    Inamoto, Teruo
    Hirose, Yoshinobu
    Ono, Fumihito
    Shiraishi, Yuichi
    Yoshimi, Akihide
    Azuma, Haruhito
    MOLECULAR CANCER, 2023, 22 (01)
  • [5] A Comprehensive Analysis of FGF/FGFR Signaling Alteration in NSCLC: Implications in Prognosis and Microenvironment
    Huang, Ziling
    Li, Leyao
    Cai, Xu
    Wang, Shen
    Jia, Yun
    Li, Yuan
    THORACIC CANCER, 2025, 16 (04)
  • [6] The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
    Kazumasa Komura
    Kensuke Hirosuna
    Satoshi Tokushige
    Takuya Tsujino
    Kazuki Nishimura
    Mitsuaki Ishida
    Takuo Hayashi
    Ayako Ura
    Takaya Ohno
    Shogo Yamazaki
    Keita Nakamori
    Shoko Kinoshita
    Ryoichi Maenosono
    Masahiko Ajiro
    Yuki Yoshikawa
    Tomoaki Takai
    Takeshi Tsutsumi
    Kohei Taniguchi
    Tomohito Tanaka
    Kiyoshi Takahara
    Tsuyoshi Konuma
    Teruo Inamoto
    Yoshinobu Hirose
    Fumihito Ono
    Yuichi Shiraishi
    Akihide Yoshimi
    Haruhito Azuma
    Molecular Cancer, 22
  • [7] Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade
    Oh, Kyu-Young
    Hong, Seong-Doo
    Yoon, Hye-Jung
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2024, 53 (03) : 217 - 225
  • [8] Targeting FGFR signaling with FGFR inhibitor-based regimens: UCSD molecular tumor board experience
    Uehara, Y.
    Sadakatsu, I.
    Sicklick, J. K.
    Persha, H.
    Jimenez, R.
    Kim, K. H.
    Lim, H. J.
    Lee, S.
    Okamura, R.
    Kato, S.
    Kurzrock, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S1220 - S1220
  • [9] The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
    Petitprez, Florent
    Meylan, Maxime
    de Reynies, Aurelien
    Sautes-Fridman, Catherine
    Fridman, Wolf H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [10] Effect of FGFR alteration on prognosis in 1963 urothelial carcinoma patients with immune checkpoint inhibitors: Implying combination of FGFR inhibitor and immunotherapy for FGFR-altered urothelial carcinoma
    Song, Yuxuan
    Jiang, Shan
    Peng, Yun
    Qin, Caipeng
    Du, Yiqing
    Xu, Tao
    PHARMACOLOGICAL RESEARCH, 2024, 205
12345